These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6456150)

  • 1. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
    Higatsberger MR; Sperk G; Bernheimer H; Shannak KS; Hornykiewicz O
    Exp Brain Res; 1981; 44(1):93-6. PubMed ID: 6456150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
    Schoemaker H; Morelli M; Deshmukh P; Yamamura HI
    Brain Res; 1982 Sep; 248(2):396-401. PubMed ID: 6291702
    [No Abstract]   [Full Text] [Related]  

  • 4. Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington's disease.
    Beal MF; Marshall PE; Burd GD; Landis DM; Martin JB
    Brain Res; 1985 Dec; 361(1-2):135-45. PubMed ID: 2867808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight, feeding, and drinking behaviors in rats with kainic acid-induced lesions of striatal neurons--with a note on body weight symptomatology in Huntington's disease.
    Sanberg PR; Fibiger HC
    Exp Neurol; 1979 Dec; 66(3):444-66. PubMed ID: 158536
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
    Arregui A; Emson PC; Spokes EG
    Eur J Pharmacol; 1978 Nov; 52(1):121-4. PubMed ID: 214307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
    Friedle NM; Kelly PH; Moore KE
    Br J Pharmacol; 1978 May; 63(1):151-8. PubMed ID: 148306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's Disease.
    Mason ST; Fibiger HC
    Neuropharmacology; 1979 Apr; 18(4):403-7. PubMed ID: 36573
    [No Abstract]   [Full Text] [Related]  

  • 10. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
    Isacson O; Brundin P; Gage FH; Björklund A
    Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage.
    Coyle JT; Molliver ME; Kuhar MJ
    J Comp Neurol; 1978 Jul; 180(2):301-23. PubMed ID: 659663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease and its animal model: alterations in kainic acid binding.
    Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
    Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
    [No Abstract]   [Full Text] [Related]  

  • 13. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
    Mason ST; Fibiger HC
    Brain Res; 1978 Oct; 155(2):313-29. PubMed ID: 28817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of beta-adrenoceptor binding sites in rat striatum following kainic acid lesions.
    Nahorski SR; Howlett DR; Redgrave P
    Eur J Pharmacol; 1979 Dec; 60(2-3):249-52. PubMed ID: 230980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease.
    Sanberg PR; Lehmann J; Fibiger HC
    Brain Res; 1978 Jun; 149(2):546-51. PubMed ID: 27285
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 2-dimethylaminoethanol in kainate-lesioned rat striatum: anomaly in the radioenzymatic assay of acetylcholine.
    London ED; Harris LW; Heyl WC; Coyle JT
    Commun Psychopharmacol; 1978; 2(4):357-64. PubMed ID: 153218
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum.
    Wong PT; McGeer EG; McGeer PL
    J Neurosci Res; 1982; 8(4):643-50. PubMed ID: 6131142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme in kainic acid--injected striata.
    Singh EA; McGeer EG
    Ann Neurol; 1978 Jul; 4(1):85-6. PubMed ID: 211933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensatory bilateral changes in dopamine turnover after striatal kainate lesion.
    Andersson K; Schwarcz R; Fuxe K
    Nature; 1980 Jan; 283(5742):94-6. PubMed ID: 7188627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.